StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) income statement

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1382.75−32.80 (-2.32%)

Close on Nov 18, 2026Market cap $1.30TP/E 44.9Yield 0.45%

ELI LILLY & Co income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
83.6%
Operating margin
–
Net margin
31.9%
Return on equity, FY2025
101.2%

Financial strength

Current ratio
1.39
Debt to equity
1.23
Debt to assets
33.4%
Cash to current liabilities
10.4%

Valuation

P/E ratio
44.9
Price to sales
15.04
Price to book
32.30
Dividend yield
0.45%

See a number that looks wrong?